Condition: Cardiogenic Shock · Myocardial Infarction (MI) · Fulminant Myocarditis · Sponsor: University Hospital, Basel, Switzerland
This regulation defines the purpose, the operational processes, and the organization of the registry BEAT-SHOCK (Basel Evaluation of Acute Therapy in cardiogenic SHOCK). It describes the requirements for collecting, storing, processing, managing and sharing health-related registry data.
This description comes directly from the study's public registry record.
Jasper Boeddinghaus, PD Dr. med. · 0041613287897 · jasper.boeddinghaus@usb.ch
Gregor Leibundgut, Prof. Dr. · 0041613287897 · gregor.leibundgut@usb.ch
Always discuss trial participation with your own doctor first.
| University Hospital Basel | Basel, Canton of Basel-City, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07643610